化合物PMEDAP T38514

Product Introduction
Bioactivity


英文名: PMEDAP

描述: PMEDAP 是有效的人类免疫缺陷病毒 (HIV) 复制抑制剂。它具有抗小鼠巨细胞病毒活性。它有效抑制莫罗尼鼠肉瘤病毒诱导的肿瘤形成和相关死亡率。

体内活性: In Three-week-old male NMRI mice inoculated with MSV, PMEDAP (0.25-5 mg/kg; IP; daily;) effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice. PMEDAP also suppressed tumor formation and mortality in a dose-dependent manner[2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: 0.1 M NaOH : 14.29 mg/mL (49.58 mM)


关键字: sarcoma | replication | CMV | Inhibitor | HIV | inhibit | mice | Human immunodeficiency virus | Cytomegalovirus | PMEDAP | mortality | virus

相关产品: Psoralen | Rilpivirine | GPS491 | Nandrolone decanoate | Apabetalone | L-Cycloserine | gp120-α4β7 binding inhibitor 11 | (+)-Nortrachelogenin | Valproic Acid | Panobinostat

相关库: Anti-Cancer Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Anti-Cancer Active Compound Library | Anti-Viral Compound Library | Bioactive Compound Library

化合物PMEDAP T38514信息由TargetMol中国为您提供，如您想了解更多关于化合物PMEDAP T38514报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途